A plain language review of results from the LAURA study: osimertinib after chemoradiotherapy for patients with EGFR-mutated non-small cell lung cancer that cannot be removed by surgery.


Lu S., Kato T., Dong X., Ahn M., Quang L., Soparattanapaisarn N., ...Daha Fazla

Future oncology (London, England), cilt.22, sa.11, ss.1247-1262, 2026 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 22 Sayı: 11
  • Basım Tarihi: 2026
  • Doi Numarası: 10.1080/14796694.2026.2652543
  • Dergi Adı: Future oncology (London, England)
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.1247-1262
  • Anahtar Kelimeler: EGFR-mutated, Non-small cell lung cancer, Osimertinib, Plain language review, Stage III, Unresectable
  • İstanbul Üniversitesi-Cerrahpaşa Adresli: Evet